Zika virus tested against brain tumors in animal studies
Original title: Systematic review and multilevel meta-analysis of preclinical survival outcomes of Zika virus-based oncolytic therapy in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This was only tested in animals, not in people.
The short version
In animal tests, Zika virus helped with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, but only a little.
What was studied. Researchers pooled past animal studies that used Zika virus to treat glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a serious brain tumor. Six studies met their rules, giving 38 survival results grouped into 24 sets.
What they found. Animals treated with Zika virus lived longer in the first 25 days. The average gain was 2.66 days. Results differed a lot from study to study. In some settings there may be no gain at all.
What this means, and what it doesn't
What it could mean: This is early work in animals. It suggests Zika virus is worth studying more as a possible tumor treatment. It is not something a patient can get today.
What it doesn't mean: This does not mean Zika virus treats brain tumors in people. It was only tested in animals, not in humans. The survival gain was small and did not show up in every test. This is not a cure, and it is far from everyday care. The authors say more work on safety and delivery is needed first.
Source: PubMed, August 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.